Search & Analyze
Popular Searches
Nectar Lifesciences Ltd.
Healthcare₹10.272.00%
24 Jul, 4:01 PM
CMP₹10.27
Mkt Cap₹204 Cr
P/E0.00
P/B0.35
ROE-11.23%
52W High₹22.49
52W Low₹9.20
Customise metrics bar
Stock DNA
Key Ratios
P/B Ratio
0.35
EV/EBITDA
-1.78
Dividend Yield (%)
0.00
EPS (TTM ₹)
-15.08
Book Value (₹)
29.97
ROE (%)
-11.23
ROCE (%)
-5.21
ROA (%)
-5.44
EBITDA Margin (%)
-1.55
Net Profit Margin (%)
-5.96
Debt/Equity
0.61
Current Ratio
1.21
Interest Coverage
-1.10
Asset Turnover
0.91
Working Capital/Sales
8.83
Core EBITDA Growth (%)
-113.10
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 15432.97 | 16688.32 | 15236.69 | 16840.86 | 16699.74 |
| Net Sales | 15432.97 | 16688.32 | 15236.69 | 16840.86 | 16699.74 |
| Total Income | 15546.8 | 16801.5 | 15767.26 | 17011.43 | 16774.41 |
| Total Expenditure | 14418.44 | 15102.92 | 14706.62 | 15325.33 | 16995.33 |
| Operating Profit | 1128.36 | 1698.58 | 1060.64 | 1686.1 | -220.92 |
| Depreciation | 602.53 | 569.68 | 591.19 | 607.18 | 623.89 |
| Exceptional Items | -253.15 | — | — | — | — |
| Profit Before Tax | -847.67 | 340.8 | -424.2 | 182.69 | -1615.34 |
| Tax | -115.03 | 90.33 | -182.37 | 132.74 | -478.53 |
| Profit After Tax (PAT) | -732.64 | 250.47 | -241.83 | 49.95 | -1136.81 |
| EPS (₹) | -3.27 | 1.12 | -1.08 | 0.22 | -5.07 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 224.26 | 224.26 | 224.26 | 224.26 | 224.26 |
| Reserves | 10396.04 | 10654.79 | 10421.68 | 10468.22 | 9336.81 |
| Shareholders Funds | 10620.3 | 10879.05 | 10645.94 | 10692.48 | 9561.07 |
| Total Debt | 9034.08 | 8599.25 | 7538.29 | 6355.37 | 5820.22 |
| Total Liabilities | 23758.35 | 23880.32 | 21686.41 | 21835.78 | 19921.83 |
| Total Assets | 23758.35 | 23880.32 | 21686.41 | 21835.78 | 19921.83 |
| Book Value / Share | 47.3571 | 48.5109 | 47.4714 | 47.6789 | 42.6339 |
| Assets | 23758.35 | 23880.32 | 21686.41 | 21835.78 | 19921.83 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 213.79 | 950.05 | 1336.51 | 2246.86 | 1694.38 |
| Investing Activities | -286.24 | 166.44 | 517.04 | -170.25 | -419.3 |
| Financing Activities | 114.9 | -1193.8 | -1855.83 | -2054.35 | -1280.92 |
| Net Cash Flow | 42.45 | -77.31 | -2.2800000000000002 | 22.26 | -5.84 |
NECLIFE
₹10.27
-2%